**Core Concept:** Otosclerosis is a genetic disorder characterized by the abnormal formation of bone in the middle ear, leading to conductive hearing loss and tinnitus. The disease primarily affects the stapes bone, causing fixation of the ossicles and preventing sound transmission to the inner ear.

**Why the Correct Answer is Right:** The correct answer is **D** Calcium channel blockers, specifically the group of medications known as Calcium channel blockers, can be beneficial in the management of otosclerosis. These drugs work by inhibiting calcium influx into cells, which indirectly slows down bone remodeling and prevents the rapid progression of otosclerosis.

Calcium channel blockers primarily act on the smooth muscle cells of the stapes bone, reducing the calcium influx that triggers the excessive bone formation. This results in a slower progression of the disease, improving hearing and reducing tinnitus symptoms in some patients.

**Why Each Wrong Option is Incorrect:**

A. **Option A (Anti-inflammatory drugs):** While anti-inflammatory drugs, such as corticosteroids, might provide temporary relief from symptoms, they do not address the root cause of otosclerosis and do not slow down the disease progression.

B. **Option B (Anti-convulsants):** Anti-convulsants are primarily used to treat seizures and do not have a direct impact on the progression of otosclerosis.

C. **Option C (Anti-seizure drugs):** Similar to option B, anti-seizure drugs are not specifically targeted to slow down otosclerosis progression.

**Clinical Pearl:** The use of calcium channel blockers in the early stages of otosclerosis can significantly reduce the disease progression and lead to better long-term outcomes for patients with conductive hearing loss. However, it is essential to diagnose the condition early and involve a multidisciplinary team approach, including an otolaryngologist, audiologist, and possibly a geneticist, for proper patient management.